glp-1 agonist. GLP-1R and Diabetes GLP-1 and Dual GIP/GLP-1 Agonists
Description
Diabetes Care 36 Suppl 2: S245-252, 2013
For peripapillary retinal nerve fiber layer (pRNFL) measurement, a 12 (3.4 mm) ring scan centered on the optic nerve head was used (1536 A-scans, automatic real-time tracking [ART]: 100 averaged frames) [22]
This phenomenon has been noted in the cerebrospinal fluid and brain tissue of living PD patients and in postmortem brain autopsies of those with PD
Eli Lilly , a competitor in the GLP-1 market, is also aiming to expand the use of its tirzepatide , which was approved for type 2 diabetes in 2021 under the brand name MOUNJARO and for weight loss as ZEPBOUND in late 2023
